首页 正文

Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion

{{output}}
Background and aims: Hyperinsulinemia, hyperglucagonemia, and low-grade inflammation are frequently presented in obesity and type 2 diabetes (T2D). The pathogenic regulation between hyperinsulinemia/insulin resistance (IR) and lo... ...